Endothelin-1 concentration in the ovaries was significantly lower in the PCOS group receiving EA compared with the control group, while in the hypothalamus its concentration was significantly higher in the PCOS group receiving EA than in the healthy control group. The gene discussed is EDN1; the disease is polycystic ovary syndrome.